Home
About Us
Platforms
Programs
Careers
Media
Contact
Nature highlighted Locus’ CRISPR-enhanced phage therapy for antibiotic-resistant bacterial infections in its “What to expect in 2018” article.
Posted on January 2, 2019 by
bkfrye
-
News